PTCT
PTC Therapeutics Inc
NASDAQ: PTCT · HEALTHCARE · BIOTECHNOLOGY
$65.06
+0.79% today
Updated 2026-04-30
Market cap
$5.83B
P/E ratio
8.19
P/S ratio
3.37x
EPS (TTM)
$8.58
Dividend yield
—
52W range
$36 – $88
Volume
1.2M
PTC Therapeutics Inc (PTCT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
39.40%
Operating margin
-49.60%
ROE
-7,740.00%
ROA
23.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2004 | $1.61M | — | — | — | — |
| 2005 | $4.97M | — | — | — | — |
| 2011 | $98.96M | $30.90M | 100.00% | 30.90% | 31.23% |
| 2012 | $28.78M | $-26.24M | 117.95% | -93.15% | -91.16% |
| 2013 | $31.33M | $-51.57M | -75.17% | -144.92% | -164.63% |
| 2014 | $22.96M | $-93.75M | -247.68% | -432.93% | -408.28% |
| 2015 | $36.77M | $-170.45M | 100.00% | -454.58% | -463.60% |
| 2016 | $82.70M | $-142.11M | 100.00% | -159.67% | -171.83% |
| 2017 | $194.39M | $-79.00M | 97.65% | -33.07% | -40.64% |
| 2018 | $264.73M | $-128.08M | 95.21% | -43.70% | -48.38% |
| 2019 | $306.98M | $-251.58M | 96.05% | -78.56% | -81.95% |
| 2020 | $380.77M | $-438.16M | 95.03% | -113.39% | -115.07% |
| 2021 | $538.59M | $-523.90M | 94.00% | -69.52% | -97.27% |
| 2022 | $698.80M | $-559.02M | 93.61% | -64.03% | -80.00% |
| 2023 | $937.82M | $-626.60M | 93.02% | -46.86% | -66.81% |
| 2024 | $806.78M | $-363.30M | 92.89% | -37.50% | -45.03% |
| 2025 | $1.73B | $682.64M | 95.85% | 49.49% | 39.44% |